Dr. Amy Archer: Low-Dose Steroid Maintenance Therapy May Lessen Vasculitis Flares

Relapses of ANCA-associated vasculitis (AAV) have been linked to an increase in death, reduced kidney (renal) function and end-stage renal disease (ESRD). Long-term use of steroid medications is often used to help keep AAV under control. However, there are concerns about adverse effects of the medicines, so patients and physicians…...

Read more

VPPRN Schedules Several Free Webinars, Public encouraged to participate

The VPPRN team has spent the past year coordinating a special collaborative research group known as the PCORnet Autoimmune and Systemic Inflammatory Syndromes Collaborative Research Group (ASIS CRG). With our partners we have created a series of webinars for patients to learn about issues important to them. Glucocorticoids (steroids): A…...

Read more

VPPRN Continues to Grow Beyond Expectations As it Studies Data Related to Vasculitis Patients

The Impact of Participation Thank you for your support and participation with the Vasculitis Patient-Powered Research Network! In three years our Network has grown to over 2,000 participants in 29 different countries representing 13 of the vasculitides. There is strength in numbers. Every participant in the VPPRN helps to make…...

Read more

Beth Westbrook Joins the VF as Director of Development

The Vasculitis Foundation is pleased to introduce Beth Westbrook, who brings a career in nonprofit development leadership to the organization. Beth’s experiences—both personally and professionally—make her uniquely qualified to help the VF to grow stronger in the coming years. Dear Friends, As the newest addition to the team at the…...

Read more

Dr. Patrick Nachman Building New Multidisciplinary Vasculitis Program at the University of Minnesota in Minneapolis

Patrick Nachman, MD, FASN, is the new director of the Division of Renal Diseases and Hypertension at the University of Minnesota in Minneapolis. Prior to that, he was at the University of North Carolina, where his research focus has been on ANCA-associated vasculitis (AAV) since 1992. Dr. Nachman is a…...

Read more